Alvin Shih

CIK: 0001610064

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ZVRA

ZEVRA THERAPEUTICS, INC.

Director

OACC

Oaktree Acquisition Corp. III Life Sciences

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 4, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Sep 12, 2025
Purchase(P)
Direct
20K shares at avg. $7.89$158K
ZVRA
ZEVRA THERAPEUTICS, INC.
May 29, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Sep 12, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Purchase(P)	20,000	$7.89	$157,800	Direct
May 29, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct

1-3 of 3 transactions

About Shih Alvin

Shih Alvin (SEC CIK 0001610064) files insider reports with the SEC as Director of ZEVRA THERAPEUTICS, INC. (ZVRA) and Director of Oaktree Acquisition Corp. III Life Sciences (OACC).

Signal8 holds 4 ownership filings by Shih Alvin (1 Form 3, 3 Form 4), filed between Oct 23, 2024 and Jun 18, 2026. Those filings report 3 transactions, from May 29, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Shih Alvin's filings is in BOSTON, MA.

Recent filings by Shih Alvin

Jun 4, 2026: Grant or award of ZVRA derivative securities (Form 4, code A).
Sep 12, 2025: Open-market purchase of ZVRA shares (Form 4, code P).
May 29, 2025: Grant or award of ZVRA derivative securities (Form 4, code A).

Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)

McFarlane Neil F., President and CEO
Thompson Rahsaan, Chief Legal & Compliance
Watton Corey Michael, Director
FAVORITO TAMARA A, Director
Secor Alicia, Director
Calder Douglas W, Director

How to read Form 4 transaction codes